Atlas Trials

What is the Best Interval to Screen Women 45-49 and 70-74 for Breast Cancer?

Clinical trial NCT04590560 · RECRUITING

Trial details

NCT number
NCT04590560
Sponsor
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer
Start date
2020-02-06
Primary completion
2026-02-01
Enrollment
60000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.